Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy

Journal of Rheumatology

Volumn 28, Issue 1, 2001, Pages 144-155

  Maksymowych, W P ^a   Lambert, R ^a   Jhangri, G S ^a   Leclercq, S ^a   Chiu, P ^a   Wong, B ^a   Aaron, S ^a   Russell, A S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ankylosing spondylitis; Magnetic resonance imaging; Pamidronate; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; DICLOFENAC; ETODOLAC; GADOLINIUM; HLA B27 ANTIGEN; INDOMETACIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LYMPHOCYTOPENIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPONDYLOARTHROPATHY; SYNOVITIS; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, REACTIVE; BLOOD SEDIMENTATION; BONE MARROW; C-REACTIVE PROTEIN; DIPHOSPHONATES; EDEMA; FEMALE; GADOLINIUM; HLA-B27 ANTIGEN; HUMANS; INJECTIONS, INTRAVENOUS; JOINTS; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; PULSE THERAPY, DRUG; SPONDYLITIS, ANKYLOSING; SYNOVITIS; TREATMENT OUTCOME;

EID: 0035171329     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Blood and protein loss via small intestine inflammation induced by nonsteroidal anti-inflammatory drugs
2. Side effects of NSA1Ds on the small and large intestine in humans
3. Management of refractory ankylosing spondylitis and related spondyloarthropathies
4. Sulphasalazine in the treatment of spondyloarhropathy
5. Comparison of sulphasalazine and placebo in the treatment of ankylosing spondylitis
6. Evaluation of sulphasalazine in the treatment of spondyloarthropathies
7. Further characteristics of sacroiliac inflammation in ankylosing spondylitis
8. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondyloarthropathy
9. Histopathology of early sacroilitis and enthesitis in akylosing spondylitis
10. Inhibition of antigen-presenting cell function by alendronate in vitro
11. Effect of liposomal and free bisphosphonates on the IL-1β, IL-6, and TNF-α secretion from RAW 264 cells in vitro
12. Treatment of rat arthritides with clodronate-containing liposomes
13. Effects of diphosphonates (APD, EHDP) on inflammation and bone turnover in adjuvant arthritis rats
14. Clinical and biochemical response to single, infusion of pamidronate in patients with active rheumatoid arthritis: A double blind placebo controlled study
15. Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis
16. Clinical, biochemical, and radiographic effects of aminohydroxypropylidene biphosphonate treatment in rheumatoid arthritis
17. A new approach to defining disease status in ankylosing spondylitis: The bath ankylosing spondylitis disease activity index
18. A new approach to defining functional ability in ankylosing spondylitis: The development of the bath ankylosing spondylitis functional index
19. The Bath Ankylosing Spondylitis Global Score (BAS-G)
20. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondyloarthropathy patients
21. CT-guided intraarticular corticosteroid injection into the sacroiliac joints in patients with spondyloarthropathy: Indication and follow-up with contrast-enhanced MRI
22. Magnetic resonance imaging (MRI) for detection of active sacroiliitis - A prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI
23. Early sacroiliitis in patients with spondyloarthropathy: Evaluation with dynamic gadolinium-enhanced MR imaging
24. Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: Clinical outcome and followup by dynamic magnetic resonance imaging
25. An open study of pamidronate in the treatment of refractory AS
26. The acute phase response after bisphosphonate administration
27. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate
28. Pre-ankylosing spondylitis. Histopathological report
29. Fibrocartilage in tendons and ligaments an adaptation to compressive load
30. Retrocalcaneal bursitis in spondyloarthropathy: Assessment by ultrasonography and magnetic resonance imaging
31. Achilles tendonitis in spondyloarthropathy
32. Proinflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo
33. Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate
34. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis. A controlled magnetic resonance imaging study